Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and legislation to reauthorize the Pandemic & All-Hazards Preparedness Act ("PAHPA") to include the Preparing for All Hazards & Pathogens Reauthorization Act (H.R. 4421).
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), Competitive Bidding Relief Act of 2023 (S. 1294), Consolidated Appropriations Act, 2024 (P.L. 118-42), Further Consolidated Appropriations Act, 2024 (P.L. 118-47), and Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (S. 3821).
Issues related to sterilization of medical-surgical products.
Duration: February 22, 2021
to
present
General Issues: Health Issues , Medicare/Medicaid , Environmental/Superfund , Transportation , Manufacturing , Budget/Appropriations , Veterans , Defense
Spending: about $2,930,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2021: U.S. Senate, House of Representatives, Executive Office of the President (EOP), Architect of the Capitol (AOC), Office of the Vice President of the United States
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Faith Cristol Legis. Counsel, Senator Jim Talent; Counsel, Senate Finance Committee; Prof. Staff, House Education and Workforce Committee
Faith Cristol Owens n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, OWENS & MINOR, INC. had in-house lobbyists. The report was filed on April 15.
Original Filing: 301549904.xml
Lobbying Issues
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and legislation to reauthorize the Pandemic & All-Hazards Preparedness Act ("PAHPA") to include the Preparing for All Hazards & Pathogens Reauthorization Act (H.R. 4421).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to durable medical equipment reimbursement including the DMEPOS Relief Act of 2023 (H.R. 5555), Competitive Bidding Relief Act of 2023 (S. 1294), Consolidated Appropriations Act, 2024 (P.L. 118-42), Further Consolidated Appropriations Act, 2024 (P.L. 118-47), and Supplemental Oxygen Access Reform ("SOAR") Act of 2024 (S. 3821).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to sterilization of medical-surgical products.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2023
In Q4, OWENS & MINOR, INC. had in-house lobbyists. The report was filed on Jan. 22.
Original Filing: 301535315.xml
Lobbying Issues
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and FDA regulation of medical-surgical supplies; and legislation to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA) to include the Preparing for All Hazards and Pathogens Reauthorization Act (H.R. 4421).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to competitive bidding and reimbursement of durable medical equipment (DME) including the DMEPOS Relief Act of 2023 (H.R. 5555) and the Competitive Bidding Relief Act of 2023 (S. 1294); and electronic documentation for home respiratory therapy services.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to medical-surgical supply and equipment sterilization.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2023
In Q3, OWENS & MINOR, INC. had in-house lobbyists. The report was filed on Oct. 20, 2023.
Original Filing: 301509727.xml
Lobbying Issues
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing and FDA regulation of medical-surgical supplies; and legislation to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA) to include the Preparing for All Hazards and Pathogens Reauthorization Act (H.R. 4421).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to competitive bidding and reimbursement of durable medical equipment (DME) including the DMEPOS Relief Act of 2023 (H.R. 5555) and the Competitive Bidding Relief Act of 2023 (S. 1294); and electronic documentation for home respiratory therapy services.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to medical-surgical supply and equipment sterilization.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2023
In Q2, OWENS & MINOR, INC. had in-house lobbyists. The report was filed on July 19, 2023.
Original Filing: 301481244.xml
Lobbying Issues
Issues related to the medical-surgical supply chain including onshore and near-shore sourcing, and the reauthorization of the Pandemic and All-Hazards Preparedness Act (Public Law No. 109-417).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to competitive bidding and reimbursement of durable medical equipment (DME) including the Competitive Bidding Relief Act of 2023 (S. 1294), and the end of the Covid-19 Public Health Emergency including electronic documentation for home respiratory therapy services.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to expediting critical cargo such as medical equipment at U.S. ports.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the sterilization of medical-surgical products.
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, OWENS & MINOR, INC. had in-house lobbyists. The report was filed on April 17, 2023.
Original Filing: 301453390.xml
Lobbying Issues
Issues related to the medical-surgical supply chain and covid-19; support for onshore and near-shore sourcing of medical-surgical supplies; issues related to the "PREVENT" Pandemics Act (S. 3799, 117th Congress) and the Consolidated Appropriations Act, 2022 (Pub. Law 117-328).
Agencies Lobbied
U.S. Senate
Type of Issue
Health Issues
Lobbying Issues
Issues relating to durable medical equipment (DME) including Medicare reimbursement, extending DME non-Competitive Bidding Area relief included in the "CARES" Act of 2020 (Pub. Law 116-136) and DMEPOS Relief Act of 2022 (H.R. 6641, 117th Congress); and issues related to the covid-19 public health emergency including for home respiratory therapy and diabetes supply coverage and documentation.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, OWENS & MINOR, INC. had in-house lobbyists. The report was filed on Jan. 18, 2023.
Original Filing: 301429946.xml
Lobbying Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; PREVENT Pandemics Act (S. 3799); Consolidated Appropriations Act, 2023 (Pub. Law 117-328).
Agencies Lobbied
U.S. Senate
Lobbying Issues
The domestic and near-shore manufacturing and / or finishing of medical-surgical supplies; Consolidated Appropriations Act, 2023 (Pub. Law 117-328).
Agencies Lobbied
U.S. Senate
Type of Issue
Budget/Appropriations
Lobbying Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Consolidated Appropriations Act, 2023 (Pub. Law 117-328).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues relating to durable medical equipment (DME) including Medicare reimbursement, sequestration and "PAYGO" relief, extending DME non-Competitive Bidding area relief included in the "CARES" Act of 2020 (Pub. Law 116-136); issues related to the COVID-19 public health emergency including for home respiratory therapy coverage and documentation; DMEPOS Relief Act of 2022 (H.R. 6641); Expanded Telehealth Access Act (H.R. 2168); Consolidated Appropriations Act, 2023 (Pub. Law 117-328).
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, OWENS & MINOR, INC. had in-house lobbyists. The report was filed on Oct. 12, 2022.
Original Filing: 301402963.xml
Lobbying Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Infrastructure Investment and Jobs Act (Public Law 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260); Coronavirus Aid, Relief, and Economic Security Act (Public Law 116-136); DMEPOS Relief Act of 2022 (H.R. 6641); Statutory Pay-As-You-Go Act of 2010
Agencies Lobbied
U.S. Senate
Lobbying Issues
The domestic and near-shore manufacturing and / or finishing of medical-surgical supplies; FY23 Appropriations Funding
Agencies Lobbied
U.S. Senate
Type of Issue
Budget/Appropriations
Lobbying Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, OWENS & MINOR, INC. had in-house lobbyists. The report was filed on July 19, 2022.
Original Filing: 301384472.xml
Lobbying Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Agencies Lobbied
U.S. Senate
Lobbying Issues
The domestic and near-shore manufacturing and / or finishing of medical-surgical supplies; FY23 Appropriations Funding
Agencies Lobbied
U.S. Senate
Type of Issue
Budget/Appropriations
Lobbying Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, OWENS & MINOR, INC. had in-house lobbyists. The report was filed on April 15, 2022.
Original Filing: 301356492.xml
Lobbying Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306); Masks for All Act (H.R. 6385); PREVENT Pandemics Act (S. 3799); America COMPETES Act of 2022 (H.R. 4521); United States Innovation and Competition Act of 2021 (S. 1260)
Agencies Lobbied
U.S. Senate
Lobbying Issues
The domestic and near-shore manufacturing and / or finishing of medical-surgical supplies; FY23 Appropriations Funding
Agencies Lobbied
U.S. Senate
Lobbying Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, OWENS & MINOR, INC. had in-house lobbyists. The report was filed on Jan. 19, 2022.
Original Filing: 301327427.xml
Lobbying Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies; Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Infrastructure Investment and Jobs Act (Public Law No: 117-58), which includes Make PPE in America Act (H.R. 2720, S. 1306)
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Defense Authorization Act for Fiscal Year 2022 (Public Law No: 117-81); Manufacture and distribution of medical-surgical supplies including PPE products and the provision of solutions and expertise that support U.S. military efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support for Domestic and Near-Shore Manufacture of PPE; Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022 (H.R. 4502); Department of Homeland Security Appropriations Act, 2022 (H.R. 4431)
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, OWENS & MINOR, INC. had in-house lobbyists. The report was filed on Oct. 18, 2021.
Original Filing: 301301687.xml
Lobbying Issues
Personal Protective Equipment (PPE) Supply Chain and COVID-19; Strategic National Stockpile; Support for Onshore and Near-Shore Sourcing of Medical-Surgical Supplies including PPE; United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306); Protecting Providers Everywhere (PPE) in America Act (H.R. 1436; S. 308); Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); INVEST in America Act (H.R. 3684)
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Defense Authorization Act for Fiscal Year 2022 (H.R. 4350; S. 2792); Manufacture and distribution of medical-surgical supplies including PPE products and the provision of solutions and expertise that support U.S. military efforts.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Personal Protective Equipment (PPE) Supply Chain and Manufacture and COVID-19; United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306); INVEST in America Act (H.R. 3864)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Support for Domestic Manufacture and Sourcing of PPE; Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022 (H.R. 4502); Department of Homeland Security Appropriations Act, 2022 (H.R. 4431)
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, OWENS & MINOR, INC. had in-house lobbyists. The report was filed on July 6, 2021.
Original Filing: 301273622.xml
Lobbying Issues
Appropriations for medical/surgical Personal Protective Equipment ("PPE"); United States Innovation and Competition Act of 2021 (S. 1260); Make PPE in America Act (H.R. 2720, S. 1306); Medical Supplies for Pandemics Act of 2021 (H.R. 3463; S. 1693); Strengthening Americas Strategic National Stockpile Act of 2021 (H.R. 3635; S. 1974); Addressing U.S. Port Congestion
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Defense Authorization Act for Fiscal Year 2022: Manufacture and distribution of medical/surgical PPE products and the provision of solutions and expertise that support U.S. military efforts.
1st Quarter, 2021
In Q1, OWENS & MINOR, INC. had in-house lobbyists. The report was filed on April 20, 2021.
Original Filing: 301262621.xml
Lobbying Issues
Manufacture and distribution of medical/surgical PPE products and the provision of solutions and expertise that support critical patient care.
PPE supply chain and COVID-19.
Strategic National Stockpile.
Appropriations for medical/surgical PPE.
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
OWENS & MINOR, INC. filed a lobbying registration on Feb. 25, 2021 for in-house lobbying efforts, effective Feb. 22, 2021.
Original Filing: 301248985.xml
Issue(s) they said they’d lobby about: Legislative and regulatory proposals affecting the healthcare industry, including the manufacture and distribution of surgical and PPE products and the provision of solutions and expertise that support critical patient care. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...